Conduit Pharmaceuticals Statistics
Total Valuation
CDT has a market cap or net worth of $1.38 million. The enterprise value is $3.89 million.
Important Dates
The next estimated earnings date is Tuesday, March 4, 2025, after market close.
| Earnings Date | Mar 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CDT has 1.20 million shares outstanding. The number of shares has increased by 24.50% in one year.
| Current Share Class | 1.20M |
| Shares Outstanding | 1.20M |
| Shares Change (YoY) | +24.50% |
| Shares Change (QoQ) | +18.01% |
| Owned by Insiders (%) | 4.97% |
| Owned by Institutions (%) | 8.78% |
| Float | 741,693 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | -0.15 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.12
| Current Ratio | 0.12 |
| Quick Ratio | 0.03 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -16.15 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -108.80% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 145.43% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.16M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.61% in the last 52 weeks. The beta is 2.16, so CDT's price volatility has been higher than the market average.
| Beta (5Y) | 2.16 |
| 52-Week Price Change | -99.61% |
| 50-Day Moving Average | 5.43 |
| 200-Day Moving Average | 58.32 |
| Relative Strength Index (RSI) | 31.55 |
| Average Volume (20 Days) | 8,787,313 |
Short Selling Information
The latest short interest is 223,615, so 18.66% of the outstanding shares have been sold short.
| Short Interest | 223,615 |
| Short Previous Month | 4.61M |
| Short % of Shares Out | 18.66% |
| Short % of Float | 30.15% |
| Short Ratio (days to cover) | 0.29 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -13.07M |
| Pretax Income | -2.30M |
| Net Income | -15.15M |
| EBITDA | n/a |
| EBIT | -13.07M |
| Earnings Per Share (EPS) | -$23.90 |
Full Income StatementBalance Sheet
The company has $152,000 in cash and $2.67 million in debt, giving a net cash position of -$2.51 million or -$2.10 per share.
| Cash & Cash Equivalents | 152,000 |
| Total Debt | 2.67M |
| Net Cash | -2.51M |
| Net Cash Per Share | -$2.10 |
| Equity (Book Value) | -9.12M |
| Book Value Per Share | -9.50 |
| Working Capital | -10.58M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$10.67 million and capital expenditures -$51,000, giving a free cash flow of -$10.72 million.
| Operating Cash Flow | -10.67M |
| Capital Expenditures | -51,000 |
| Free Cash Flow | -10.72M |
| FCF Per Share | -$8.95 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |